Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 6 AGIO Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
May 5 AGIO Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
May 3 AEON Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why
May 3 AGIO Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
May 3 AGIO Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2024 Earnings Call Transcript
May 3 AGIO Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
May 3 AGIO Agios Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 3 AGIO Agios Pharmaceuticals Inc (AGIO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 3 AGIO Q1 2024 Agios Pharmaceuticals Inc Earnings Call
May 2 ADMA Adma Biologics (ADMA) Rises Higher Than Market: Key Facts
May 2 AGIO Agios Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 2 AGIO Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript
May 2 AGIO Agios Pharmaceuticals Reports Q1 2024 Earnings: Narrower Loss than Expected with Strong Revenue ...
May 2 AGIO Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
May 2 AGIO Agios Pharmaceuticals GAAP EPS of -$1.45 beats by $0.20, revenue of $8.19M misses by $0.18M
May 2 AGIO Agios Reports Business Highlights and First Quarter 2024 Financial Results
May 2 ADMA ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
May 1 AGIO Agios Pharmaceuticals Q1 2024 Earnings Preview
May 1 ADAP Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
May 1 AEZS Aeterna Zentaris Announces Effective Date of Share Consolidation
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags